Literature DB >> 26688706

Multiple primary colorectal cancer: Individual or familial predisposition?

José A Pajares1, José Perea1.   

Abstract

Colorectal carcinoma (CRC) is one of the most frequent cancers. Along the surface of the large bowel, several foci of CRC may appear simultaneously or over the time. The development of at least two different tumours has been defined as multiple primary CRC (MPCRC): When more than one tumour is diagnosed at the same time, it is known as synchronous CRC (SCRC), while when a second neoplasm is diagnosed some time after the resection and/or diagnosis of the first lesion, it is called metachronous CRC (MCRC). Multiple issues can promote the development of MPCRC, ranging from different personal factors, such as environmental exposure, to familial predisposition due to hereditary factors. However, most studies do not distinguish this dichotomy. High- and low-pentrance genetic variants are involved in MPCRC. An increased risk for MPCRC has been described in Lynch syndrome, familial adenomatous polyposis, and serrated polyposis. Non-syndromic familial CRCs should also be considered as risk factors for MPCRC. Environmental factors can promote damage to colon mucosae that enable the concurrence of MPCRC. Epigenetics are thought to play a major role in the carcinogenesis of sporadic MPCRC. The methylation state of the DNA depends on multiple environmental factors (e.g., smoking and eating foods cooked at high temperatures), and this can contribute to increasing the MPCRC rate. Certain clinical features may also suggest individual predisposition for MPCRC. Different etiopathogenic factors are suspected to be involved in SCRC and MCRC, and different familial vs individual factors may be implicated. MCRC seems to follow a familial pattern, whereas individual factors are more important in SCRC. Further studies must be carried out to know the molecular basis of risks for MPCRC in order to modify, if necessary, its clinical management, especially from a preventive point of view.

Entities:  

Keywords:  Chromosomal instability; CpG island methylator phenotype; Metachronous colorectal cancer; Microsatellite instabillity; Multiple primary colorectal cancer; Synchronous colorectal cancer

Year:  2015        PMID: 26688706      PMCID: PMC4678390          DOI: 10.4251/wjgo.v7.i12.434

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  56 in total

1.  Familial colorectal cancer risk: ESMO Clinical Practice Guidelines.

Authors:  J Balmaña; A Castells; A Cervantes
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Accelerated age-related CpG island methylation in ulcerative colitis.

Authors:  J P Issa; N Ahuja; M Toyota; M P Bronner; T A Brentnall
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

3.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  Drawing up an individual risk index for development of metachronous neoplastic lesions in resected colorectal cancer.

Authors:  Ana Borda; José María Martínez-Peñuela; Fernando Borda; Miguel Muñoz-Navas; Francisco Javier Jiménez; Cristina Carretero
Journal:  Rev Esp Enferm Dig       Date:  2012-06       Impact factor: 2.086

5.  Flat adenomas exist in asymptomatic people: important implications for colorectal cancer screening programmes.

Authors:  A R Hart; S Kudo; E H Mackay; J F Mayberry; W S Atkin
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

6.  Evidence of a preferred molecular pathway in patients with synchronous colorectal cancer.

Authors:  Sharon L Dykes; Hongming Qui; David A Rothenberger; Julio García-Aguilar
Journal:  Cancer       Date:  2003-07-01       Impact factor: 6.860

7.  The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer.

Authors:  Wade S Samowitz; Karen Curtin; Roger K Wolff; Hans Albertsen; Carol Sweeney; Bette J Caan; Cornelia M Ulrich; John D Potter; Martha L Slattery
Journal:  Genes Chromosomes Cancer       Date:  2008-10       Impact factor: 5.006

8.  [Synchronous neoplastic lesions in colorectal cancer. An analysis of possible risk factors favouring presentation].

Authors:  A Borda; J M Martínez-Peñuela; M Muñoz-Navas; C Prieto; M Betés; F Borda
Journal:  Rev Esp Enferm Dig       Date:  2008-03       Impact factor: 2.086

9.  Synchronous and metachronous malignancies of the colon and rectum in Japan with special reference to a coexisting early cancer.

Authors:  N Kaibara; S Koga; D Jinnai
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

10.  Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors.

Authors:  Virgínia Piñol; Montserrat Andreu; Antoni Castells; Artemio Payá; Xavier Bessa; Rodrigo Jover
Journal:  Dis Colon Rectum       Date:  2004-05-28       Impact factor: 4.585

View more
  7 in total

1.  Redefining synchronous colorectal cancers based on tumor clonality.

Authors:  José Perea; Juan L García; Luis Corchete; Eva Lumbreras; María Arriba; Daniel Rueda; Sandra Tapial; Jessica Pérez; Victoria Vieiro; Yolanda Rodríguez; Lorena Brandáriz; Mariano García-Arranz; Damián García-Olmo; Ajay Goel; Miguel Urioste; Rogelio González Sarmiento
Journal:  Int J Cancer       Date:  2018-10-16       Impact factor: 7.396

2.  Risk of multiple colorectal cancer development depends on age and subgroup in individuals with hereditary predisposition.

Authors:  Lars J Lindberg; Wia Wegen-Haitsma; Steen Ladelund; Lars Smith-Hansen; Christina Therkildsen; Inge Bernstein; Mef Nilbert
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

3.  Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer?

Authors:  Wanbin He; Mingtian Wei; Xuyang Yang; Bingchen Chen; Qingbin Wu; Erliang Zheng; XiangBing Deng; Ziqiang Wang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

4.  A lethal synergy induced by phellinus linteus and camptothecin11 in colon cancer cells.

Authors:  Tianqi Yu; Suthakar Ganapathy; Ling Shen; Bo Peng; Sung-Hoon Kim; Alexandros Makriyannis; Changyan Chen
Journal:  Oncotarget       Date:  2018-01-04

5.  Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors.

Authors:  Juan Carlos Andreu-Ballester; Lorena Galindo-Regal; Julia Hidalgo-Coloma; Carmen Cuéllar; Carlos García-Ballesteros; Carolina Hurtado; Natalia Uribe; María Del Carmen Martín; Ana Isabel Jiménez; Francisca López-Chuliá; Antonio Llombart-Cussac
Journal:  PLoS One       Date:  2020-12-16       Impact factor: 3.240

6.  Comment on 'Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system'.

Authors:  Sandra Tapial; Daniel Rueda; María Arriba; Juan Luis García; Lorena Brandáriz; Jessica Pérez; Yolanda Rodríguez; Damián García-Olmo; Rogelio González-Sarmiento; Miguel Urioste; José Perea
Journal:  Br J Cancer       Date:  2018-01-02       Impact factor: 7.640

Review 7.  Simultaneous curative resection of double colorectal carcinoma with synchronous bilobar liver metastases.

Authors:  Emilio De Raffele; Mariateresa Mirarchi; Dajana Cuicchi; Ferdinando Lecce; Claudio Ricci; Riccardo Casadei; Bruno Cola; Francesco Minni
Journal:  World J Gastrointest Oncol       Date:  2018-10-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.